| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/31/2009 | US7511190 Expressing a polypeptide encoded by a preferred polynucleotide sequence in a plant and detecting at least one factor that is modulated by or interacts with such polypeptide |
| 03/31/2009 | US7511129 Genetically engineered DNA transfer vector comprising a polynucleotide sequence that encodes a toxin comprising an insecticidal fragment |
| 03/31/2009 | US7511126 Position-independent and tissue specific expression of a transgene in milk of transgenic animals |
| 03/31/2009 | US7511124 immunoconjugate and duramycin-based compositions and combinations that bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases; kits |
| 03/31/2009 | US7511123 Binding to antigen; controlling concentration |
| 03/31/2009 | US7511122 Monoclonal and chimeric antibodies that bind to lipoteichoic acid of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal; light and heavy chains comprising complementarity determining regions |
| 03/31/2009 | US7511121 Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors |
| 03/31/2009 | US7511095 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith |
| 03/31/2009 | US7511094 2-methylbutyraldehyde diethyl acetal end capped polyoxyethylene glycol; polyalkylene oxide, polyivnylpyrrolidone, polyvinyl alcohol, polyoxazoline etc. endcapped with polyetherpolyamine copolymers or oligomers covalently attached to diacetal tetramethylene group |
| 03/31/2009 | US7511024 Factor VII or VIIA-like molecules |
| 03/31/2009 | US7511019 Method for treating a human patient for coronary artery disease, comprising administering into one or more coronary vessels in a human patient in need of treatment for coronary artery disease an effective amount of a recombinant fibroblast |
| 03/31/2009 | US7511018 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
| 03/31/2009 | US7511017 Inhibiting apoptosis associated with HIV infection; immunoglobulin constant domain heterologous polypeptide; isolated nucleic acid encoding a human polypeptide, tumor necrosis factor receptor-5 |
| 03/31/2009 | US7511015 Ribosylated human neutrophil peptide-1or an ADP-ribosylated human neutrophil peptide-1; modified antimicrobial activity compared to alpha defensin lacking ADP-ribosylated or ribosylated residue; altered chemotaxis of T cells, altered neutrophil recruitment |
| 03/31/2009 | US7511012 Myostatin binding agents |
| 03/31/2009 | US7511011 Synthetic lipid mixtures for the preparation of a reconstituted surfactant |
| 03/31/2009 | US7511009 Recombinant DNA of a gene having a DNA sequence or amino acid sequence; antitumor agents |
| 03/31/2009 | US7510878 Bacillus thuringiensis gene with lepidopteran activity |
| 03/31/2009 | US7510875 Methods for producing purified adenoviral vectors |
| 03/31/2009 | US7510874 Stable cell lines expressing HERG1a and HERG1b |
| 03/31/2009 | US7510872 Transgenic cell comprising adenoviral vector for use as gene delivery tool; tissue engineering heterologous gene expression; DNA vaccines |
| 03/31/2009 | US7510870 STAT3 activated stem cell |
| 03/31/2009 | US7510867 Expression may be controlled by a regulatory element along with a small polyadenylation signal; entire gene expression cassettes may be packaged into a viral vector, preferably an adeno-associated virus vector; five or six rod repeats; cysteine-rich domain; muscular dystrophy |
| 03/31/2009 | US7510863 Nucleotide sequence coding single stranded RNA viral sequences for use in generation antibodies to prevent, treat and diagnose respiratory system disorders in poultry; veterinary medicine |
| 03/31/2009 | US7510862 Nucleic acid comprising retroviral sequences for use as tools in generation of vaccines for prevention of viral diseases and infection; immunotherapy; viricides, antisense agents |
| 03/31/2009 | US7510855 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 03/31/2009 | US7510854 Using transgenic gramnegative bacteria as biorecator for fermentation of methione and lysine for use in medicine, cosmetics and animal feeds |
| 03/31/2009 | US7510853 Exhibiting similarity to cytokine; isolated or recombinant polynucleotide encoding antigenic polypeptide of sequence 2 |
| 03/31/2009 | US7510847 Drug screening for compound having uricosuric regulating action by incubating a transformed cell expressing a recombinant protein with uric acid; and determining an uptake of uric acid; gout |
| 03/31/2009 | US7510846 Assay employing human or rat GAL-R2 galanin receptor |
| 03/31/2009 | US7510845 Using g protein coupled receptor to identifying modulator for use in treatment and prevention of pain; antinociceptive agents |
| 03/31/2009 | US7510843 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 03/31/2009 | US7510840 Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibody |
| 03/31/2009 | US7510835 Methods for identifying risk of breast cancer and treatments thereof |
| 03/31/2009 | US7510831 Expression vector comprising nucleotide sequences coding phytase for use in transformation and expression in aspergillus; enhancing nutrient quality of animal feeds |
| 03/31/2009 | US7510828 Therapy, prevention of viral infections; obtaining viron sample; incubation, monitoring, calibration: using antithrombin agent |
| 03/31/2009 | US7510707 PAR, a novel marker gene for breast and prostate cancers |
| 03/31/2009 | CA2494888C Substances for preventing and treating autoimmune diseases |
| 03/31/2009 | CA2289961C A gene causative of rheumatoid arthritis, method for diagnosing rheumatoid arthritis, and method for identifying causative factors of rheumatoid arthritis |
| 03/31/2009 | CA2210139C Immunogenic conjugate molecules |
| 03/31/2009 | CA2066204C Cystic fibrosis gene |
| 03/26/2009 | WO2009039414A2 Methods and compositions for detection of ehrlichia chaffeensis (vlpt) |
| 03/26/2009 | WO2009039217A1 Medicaments for the treatment of coronary syndromes |
| 03/26/2009 | WO2009038889A1 Fhbp- and lpxl1-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 03/26/2009 | WO2009038880A1 Novel e-selectin variant |
| 03/26/2009 | WO2009038700A1 Diagnosis and treatment of cancer using cancer-testis antigens |
| 03/26/2009 | WO2009038475A1 Systems for expression of heterologous proteins in m. capsulatus |
| 03/26/2009 | WO2009038462A1 Use of aav replication machinery for improved protein production |
| 03/26/2009 | WO2009037566A2 Hyaluronidase and method of use thereof |
| 03/26/2009 | WO2009037502A1 Modified xylan production |
| 03/26/2009 | WO2009037402A2 Hpiv-2 variants and medical applications thereof |
| 03/26/2009 | WO2009037279A1 Plants with increased yield |
| 03/26/2009 | WO2009037183A2 Cosmetic and/or pharmaceutical preparation containing nucleic acid for the induction of antimicrobial peptides in epithelia |
| 03/26/2009 | WO2009036949A1 Hypoallergenic variants of the major allergen from betula verrucosa pollen |
| 03/26/2009 | WO2009036842A1 Method for reducing the number of viruses and microorganisms in biological extracts containing solids, and extracts produced according to this method |
| 03/26/2009 | WO2009036574A1 Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening |
| 03/26/2009 | WO2009036510A1 Novel avian cytokines and genetic sequences encoding same |
| 03/26/2009 | WO2009013020A3 Inhibitor of the met-receptor and its use |
| 03/26/2009 | WO2009010874A3 Preprocalcitonin antigen t epitopes |
| 03/26/2009 | WO2009003732A3 Peptides with high affinity for the prolactin receptor |
| 03/26/2009 | WO2008157729A3 Methods for predicting three-dimensional structures for alpha helical membrane proteins and their use in design of selective ligands |
| 03/26/2009 | WO2008157697A3 Copolymer assay |
| 03/26/2009 | WO2008121437A3 Trophinin-binding peptides and uses thereof |
| 03/26/2009 | WO2008112008A3 Sensor proteins and assay methods |
| 03/26/2009 | WO2008109079A3 High purity peptides |
| 03/26/2009 | WO2008104804A3 Proteins |
| 03/26/2009 | WO2008097366A3 Metabolically engineered escherichia coli for enchanced production of sialic acid |
| 03/26/2009 | WO2007008547A3 Sp35 antibodies and uses thereof |
| 03/26/2009 | WO2005076972A3 Chimeric vegf peptides |
| 03/26/2009 | WO2005017096A3 SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF |
| 03/26/2009 | WO2005014615A3 Self-assembling peptides incorporating modifications and methods of use thereof |
| 03/26/2009 | WO2004096993A3 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 03/26/2009 | WO2004094651A3 Novel human polypeptides encoded by polynucleotides |
| 03/26/2009 | WO2004093804A3 Human polypeptides encoded by polynucleotides and methods of their use |
| 03/26/2009 | WO2004064612A3 Regulation of tgf-b signaling by tomoregulin |
| 03/26/2009 | US20090083886 Transgenic plants with increased glycine-betaine |
| 03/26/2009 | US20090083880 Modified plant defensin |
| 03/26/2009 | US20090083877 Transcription Factors, DNA and Methods for Introduction of Value-Added Seed Traits and Stress Tolerance |
| 03/26/2009 | US20090083863 p300 transgenic animal |
| 03/26/2009 | US20090082551 Method, compositions and classification for tumor diagnostics and treatment |
| 03/26/2009 | US20090082537 Four branched dendrimer-peg for conjugation to proteins and peptides |
| 03/26/2009 | US20090082410 Constitutively translocating cell line |
| 03/26/2009 | US20090082296 Mycobacterial antigens expressed during latency |
| 03/26/2009 | US20090082289 Adenoviral vectors having a protein IX deletion |
| 03/26/2009 | US20090082279 Treating a condition associated with breakdown of the blood brain barrier by administering a peptide antagonist of zonulin that binds to the zonula occludens receptor, especially in the brain, yet does not physiologically modulate the opening of mammalian tight junctions |
| 03/26/2009 | US20090082276 Selective vpac2 receptor peptide agonists |
| 03/26/2009 | US20090082275 Ob protein compositions and methods |
| 03/26/2009 | US20090082274 Collections of repeat proteins comprising repeat modules |
| 03/26/2009 | US20090082273 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 03/26/2009 | US20090082272 pharmacokinetics; sustained release; cost efficiency; industrial scale |
| 03/26/2009 | US20090082270 myostatin antagonist protein is substantially serum stable for a period of at least 24 hours; treating individuals with muscle wasting conditions and provides further insight into the regulation of myostatin gene expression; muscular disorders |
| 03/26/2009 | US20090082269 Agent for ameliorating heavy metal-induced disorders, and medicinal composition, food and cosmetic containing the same |
| 03/26/2009 | US20090082267 Prevention and Reduction of Blood Loss |
| 03/26/2009 | US20090082265 Compositions and methods for treating diseases |
| 03/26/2009 | US20090082264 123 Human Secreted Proteins |
| 03/26/2009 | US20090082263 Drug and method for improving brain function |
| 03/26/2009 | US20090082262 Processed human chemokines PHC-1 and PHC-2 |
| 03/26/2009 | US20090082261 Urea-containing peptides as inhibitors of viral replication |
| 03/26/2009 | US20090082257 MalPEG-Hb conjugate- containing compositions for delivering carbon monoxide (CO) to cells |
| 03/26/2009 | US20090081798 Protein S Functional Assay |